TrialPanorama/TrialPanorama-database huggingface dataset:
Study 34746886 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 34746903 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34746903 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34746970 — Predictive Biomarker (PRD): PAPOLB mRNA
Genes: PAPOLB; PAPT
Study 34748144 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34748572 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 34748951 — Predictive Biomarker (PRD): NOS2 mRNA
Genes: NOS2; NOS2A
Study 34749638 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study 34749654 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 34749788 — Surrogate Endpoint (SUR): Blood pressure
Study 34749788 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34749816 — Predictive Biomarker (PRD): DBF4 mRNA
Genes: DBF4; ASK; DBF4A; ZDBF1
Study 34749885 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 34749885 — Predictive Biomarker (PRD): SHC1 mRNA
Genes: SHC1; SHC; SHCA
Study 34750014 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34750014 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34750014 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 34750057 — Surrogate Endpoint (SUR): Blood pressure
Study 34750081 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34751159 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34751514 — Surrogate Endpoint (SUR): Blood pressure
Study 34753703 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34753703 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 34753777 — Predictive Biomarker (PRD): CCR4 mRNA
Genes: CCR4; CMKBR4
Study 34753870 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34754076 — Safety Biomarker (SAF): Interleukin 12
Study 34754193 — Surrogate Endpoint (SUR): Serum calcium
Study 34754193 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 34756943 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study 34757194 — Predictive Biomarker (PRD): KLRC1 mRNA
Genes: KLRC1; NKG2A
Study 34757194 — Predictive Biomarker (PRD): TLR2
Genes: TIL4; CD282
Study 34757489 — Safety Biomarker (SAF): PPOX
Genes: HCRT; OX
Study 34757489 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study 34760951 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34761647 — Monitoring Biomarker (MOI): Cell-free DNA
Study 34761665 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 34761878 — Surrogate Endpoint (SUR): Pathological complete response
Study 34762062 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34762093 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 34762658 — Predictive Biomarker (PRD): CASP3 mRNA
Genes: CASP3; CPP32
Study 34762658 — Predictive Biomarker (PRD): BAX mRNA
Genes: BAX; BCL2L4
Study 34762658 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 34762658 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 34762658 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study 34763085 — Predictive Biomarker (PRD): DDC mRNA
Genes: DDC; AADC
Study 34763195 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34763776 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 34764171 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34764938 — Predictive Biomarker (PRD): PTPRU mRNA
Genes: PTPRU; FMI; PCP2; PTPRO
Study 34766217 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 34766576 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34767652 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 34767785 — Predictive Biomarker (PRD): SMOX mRNA
Genes: SMOX; C20orf16; SMO; UNQ3039/PRO9854
Study 34767825 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 34768339 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 34768571 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 34768571 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 34771451 — Predictive Biomarker (PRD): PAFAH1B1 mRNA
Genes: PAFAH1B1; LIS1; MDCR; MDS; PAFAHA
Study 34772758 — Predictive Biomarker (PRD): ICOS mRNA
Genes: ICOS; AILIM
Study 34772758 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study 34772767 — Surrogate Endpoint (SUR): Blood pressure
Study 34774107 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study 34774107 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 34774107 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study 34774107 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 34774107 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study 34774107 — Pharmacodynamic Biomarker (PDY): T-lymphocyte activation antigen CD86
Genes: CD86; CD28LG2
Study 34774107 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study 34774107 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34774574 — Surrogate Endpoint (SUR): Blood pressure
Study 34775477 — Predictive Biomarker (PRD): PIK3R5 mRNA
Genes: PIK3R5
Study 34775477 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34775592 — Predictive Biomarker (PRD): KLRC2 mRNA
Genes: KLRC2; NKG2C
Study 34777337 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study 34777337 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 34777337 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34777341 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 34777367 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34778952 — Surrogate Endpoint (SUR): Serum creatinine
Study 34779146 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 34779146 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34779146 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 34779146 — Predictive Biomarker (PRD): GATA3 mRNA
Genes: GATA3
Study 34779146 — Predictive Biomarker (PRD): HRAS mRNA
Genes: HRAS; HRAS1
Study 34779146 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 34779146 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 34779146 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 34779245 — Surrogate Endpoint (SUR): Blood pressure
Study 34780106 — Predictive Biomarker (PRD): BTG2 mRNA
Genes: BTG2; PC3
Study 34780623 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 34780709 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 34780712 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 34781168 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 34782683 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34783675 — Surrogate Endpoint (SUR): Blood pressure
Study 34783716 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study 34783978 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 34783978 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 34784301 — Predictive Biomarker (PRD): MMRN1 mRNA
Genes: MMRN1; ECM; EMILIN4; GPIA*; MMRN
Study 34784359 — Surrogate Endpoint (SUR): Blood pressure
Study 34784657 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 34785545 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34785698 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study 34788506 — Predictive Biomarker (PRD): IDUA mRNA
Genes: IDUA
Study 34789141 — Predictive Biomarker (PRD): AMY1A mRNA
Genes: AMY1A; AMY1
Study 34789156 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study 34789156 — Safety Biomarker (SAF): Reactive oxygen species
Study 34789490 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34789774 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34790348 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study 34790348 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study 34790348 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 34790722 — Surrogate Endpoint (SUR): Pathological complete response
Study 34791571 — Surrogate Endpoint (SUR): Forced vital capacity
Study 34791718 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study 34792107 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 34792107 — Surrogate Endpoint (SUR): Pathological complete response
Study 34792477 — Surrogate Endpoint (SUR): Blood pressure
Study 34792477 — Surrogate Endpoint (SUR): Forced vital capacity
Study 34792559 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PSD mRNA
Genes: PSD; EFA6; EFA6A; KIAA2011; PSD1; TYL
Study 34793256 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 34793256 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 34793505 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study 34793505 — Predictive Biomarker (PRD): PYCARD mRNA
Genes: PYCARD; ASC; CARD5; TMS1
Study 34793719 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study 34793719 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34793964 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 34794172 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study 34795005 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 34795005 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 34795408 — Predictive Biomarker (PRD): PARP1 mRNA
Genes: PARP1; ADPRT; PPOL
Study 34795661 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 34795912 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 34796742 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 34797699 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 34798080 — Predictive Biomarker (PRD): HRC mRNA
Genes: HRC; HCP
Study 34798899 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 34799399 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34800109 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 34800678 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study 34800678 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 34800678 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 34801015 — Surrogate Endpoint (SUR): Serum calcium
Study 34801015 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 34801462 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 34801581 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 34801581 — Pharmacodynamic Biomarker (PDY): Insulin receptor substrate 1
Genes: IRS1
Study 34801581 — Predictive Biomarker (PRD): IRS2 mRNA
Genes: IRS2
Study 34801749 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34802467 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 34802467 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34802467 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 34802467 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 34802864 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 34802966 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34805632 — Safety Biomarker (SAF): Arachidonate 5-lipoxygenase activating protein
Genes: ALOX5AP; FLAP
Study 34806155 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 34806762 — Surrogate Endpoint (SUR): Blood pressure
Study 34806762 — Surrogate Endpoint (SUR): Serum creatinine
Study 34806998 — Surrogate Endpoint (SUR): Blood pressure
Study 34806998 — Surrogate Endpoint (SUR): Serum creatinine
Study 34806998 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 34806998 — Surrogate Endpoint (SUR): Serum uric acid
Study 34807979 — Predictive Biomarker (PRD): IL1RL1 mRNA
Genes: IL1RL1; DER4; ST2; T1
Study 34807979 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study 34807979 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 34807979 — Safety Biomarker (SAF): Interleukin 1
Study 34807979 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34808524 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34808524 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 34808524 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 34808524 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 34808524 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 34810067 — Predictive Biomarker (PRD): NPC1 mRNA
Genes: NPC1
Study 34810067 — Predictive Biomarker (PRD): NPC2 mRNA
Genes: NPC2; HE1
Study 34811954 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 34812928 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study 34812928 — Predictive Biomarker (PRD): LPP mRNA
Genes: LPP
Study 34814185 — Predictive Biomarker (PRD): TFG mRNA
Genes: TFG
Study 34814185 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study 34814190 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34814922 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 34815632 — Predictive Biomarker (PRD): UCN3 mRNA
Genes: UCN3; SPC
Study 34816288 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34816288 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34816730 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34818478 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study 34818581 — Predictive Biomarker (PRD): NRM mRNA
Genes: NRM; NRM29; UNQ555/PRO1112
Study 34819019 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34819039 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34819039 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34819039 — Predictive Biomarker (PRD): CD69 mRNA
Genes: CD69; CLEC2C
Study 34819039 — Predictive Biomarker (PRD): Hormone receptor
Study 34819138 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 1 beta
Genes: IL1B; IL1F2
Study 34819138 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study 34819138 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study 34819613 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 34819793 — Safety Biomarker (SAF): Interleukin 1
Study 34820133 — Surrogate Endpoint (SUR): Serum creatinine
Study 34822023 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 34822128 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 34824133 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 34825149 — Predictive Biomarker (PRD): EED mRNA
Genes: EED
Study 34826412 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 34826411 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 34830984 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34831060 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 34832978 — Predictive Biomarker (PRD): UCP1 mRNA
Genes: UCP1; SLC25A7; UCP
Study 34832978 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC2A4 mRNA
Genes: SLC2A4; GLUT4
Study 34832978 — Predictive Biomarker (PRD): PNPLA2 mRNA
Genes: PNPLA2; ATGL; FP17548
Study 34832978 — Predictive Biomarker (PRD): TRPM8 mRNA
Genes: TRPM8; LTRPC6; TRPP8
Study 34834511 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 34835197 — Safety Biomarker (SAF): Type I cytoskeletal 18 Keratin
Genes: KRT18; CYK18; PIG46
Study 34836504 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34836902 — Predictive Biomarker (PRD): SGCA mRNA
Genes: SGCA; ADL; DAG2
Study 34836908 — Predictive Biomarker (PRD): BAD mRNA
Genes: BAD; BBC6; BCL2L8
Study 34837382 — Surrogate Endpoint (SUR): Blood pressure
Study 34838325 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 34838325 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 34838325 — Safety Biomarker (SAF): Serine/threonine-protein kinase STK11
Genes: STK11
Study 34841462 — Surrogate Endpoint (SUR): Bone mineral density
Study 34844255 — Predictive Biomarker (PRD): NTRK
Study 34844255 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study 34844977 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study 34844980 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34845071 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 34845868 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study 34846636 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 34847232 — Predictive Biomarker (PRD): PTPN11 mRNA
Genes: PTPN11; PTP2C; SHPTP2
Study 34847232 — Predictive Biomarker (PRD): DNMT3A mRNA
Genes: DNMT3A
Study 34847232 — Predictive Biomarker (PRD): TET2 mRNA
Genes: TET2; KIAA1546; Nbla00191
Study 34847232 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 34848515 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34849303 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study 34849638 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34849677 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34849989 — Surrogate Endpoint (SUR): Bone mineral density
Study 34850014 — Predictive Biomarker (PRD): TNFRSF10A mRNA
Genes: TNFRSF10A; APO2; DR4; TRAILR1
Study 34850166 — Safety Biomarker (SAF): Interleukin 12
Study 34850167 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study 34850742 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34852172 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 34852172 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 34852175 — Predictive Biomarker (PRD): TINF2 mRNA
Genes: TINF2; TIN2
Study 34852305 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34852837 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 34853024 — Surrogate Endpoint (SUR): Blood pressure
Study 34853102 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34853430 — Predictive Biomarker (PRD): KLF12 mRNA
Genes: KLF12; AP2REP; HSPC122
Study 34853430 — Predictive Biomarker (PRD): CHST9 mRNA
Genes: CHST9; UNQ2549/PRO6175
Study 34853430 — Predictive Biomarker (PRD); Safety Biomarker (SAF): WNT5A mRNA
Genes: WNT5A
Study 34853430 — Predictive Biomarker (PRD): MBL2 mRNA
Genes: MBL2; COLEC1; MBL
Study 34853430 — Predictive Biomarker (PRD): NFKBIA mRNA
Genes: NFKBIA; IKBA; MAD3; NFKBI
Study 34853430 — Predictive Biomarker (PRD): CEP170 mRNA
Genes: CEP170; FAM68A; KAB; KIAA0470
Study 34853430 — Predictive Biomarker (PRD): MAGI2 mRNA
Genes: MAGI2; ACVRINP1; AIP1; KIAA0705
Study 34853430 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34854818 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34854818 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34855617 — Surrogate Endpoint (SUR): Blood pressure
Study 34857438 — Predictive Biomarker (PRD): FKRP mRNA
Genes: FKRP
Study 34857473 — Predictive Biomarker (PRD): MYRF mRNA
Genes: MYRF; C11orf9; KIAA0954; MRF
Study 34857585 — Surrogate Endpoint (SUR): Blood pressure
Study 34858423 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34858433 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34858433 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34858433 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study 34858433 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34858829 — Surrogate Endpoint (SUR): Pathological complete response
Study 34859304 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 34861146 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 34861154 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 34862297 — Predictive Biomarker (PRD): SMPD1 mRNA
Genes: SMPD1; ASM
Study 34862302 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34862317 — Predictive Biomarker (PRD): PNN mRNA
Genes: PNN; DRS; MEMA
Study 34862610 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 34862610 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 34862940 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 34863240 — Predictive Biomarker (PRD): GCA mRNA
Genes: GCA; GCL
Study 34863908 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 34864948 — Monitoring Biomarker (MOI): HBV DNA
Study 34864959 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein